期刊文献+

不同时间给予替米沙坦对高血压患者左室质量指数及血压变异性的影响 被引量:13

Effects of telmisartan administration time on blood pressure variability and left ventricular mass index in hypertensive patients
原文传递
导出
摘要 目的:探讨替米沙坦不同时间给药对高血压患者血压变异性(blood pressure variability,BPV)以及左心室质量指数(left ventricular mass index,LVMI)的影响。方法:将300例轻、中度非杓型原发性高血压患者随机分为3组:晨服组于晨起早8时给予替米沙坦,一次40~80 mg;晚服组于睡前晚8时给予替米沙坦,一次40~80 mg;常规组维持常规用药(非血管紧张素II受体拮抗剂及血管紧张素转化酶抑制剂),不予干涉。24周后复查动态血压和超声心动图,比较治疗前后BPV和左心室指数的变化。结果:治疗24周后血压均达标。晨服组和晚服组将非杓型血压纠正为杓型血压、恢复昼夜节律的比例分别为为22%和52.2%;晚服组患者BPV明显减小,LVMI下降,优于晨服组和常规组(P<0.05)。治疗前后,替米沙坦组有显著改变(P<0.01),对照组无明显变化。结论:采用时辰药理学给予替米沙坦可更有效地改善高血压BPV以及左心室功能,值得在临床上进一步推广。 Objective: To observe the effect of telmisartan administrated at different times on blood pressure variability(BPV) and left ventricular mass index(LVMI) in patients with hypertension.Methods:A total of 300 patients with mild to moderate essential hypertension were randomly divided into three groups.They were treated with the angiotensinⅡreceptor antagonist telmisartan 40~80 mg at 8AM(control) or at 8PM(test),as well as continued previous conventionl medication with an angiotensin II receptor antagonist and an angiotension-converting enzyme inhibitor.The change in 24-h BP and ultrasonic cardiography were determined.The values of BPV and LVMI were compared before treatment and 24 weeks after treatment.Results: The BP in all patients fit the standard 24 weeks after treatment.Circadian rhythm recovered from non-dipper variation in 22% and 52.2% patients,respectively,in 8AM and 8PM groups.BPV and LVMI decreased significantly larger in 8PM group than in 8AM and conventional groups(P〈0.05).There was a significant difference between 8AM and 8PM groups after treatment with telmisartan(P〈0.01).Conclusion: Administration of telmisartan based on chronopharmacology improves its efficacy on BPV and left ventricular function in hypertensive patients.
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第18期2178-2182,共5页 Chinese Journal of New Drugs
基金 河北省科技支撑计划项目(2011013002)
关键词 时辰药理学 替米沙坦 高血压 血压变异性 左室质量指数 chronopharmacology telmisartan hypertension blood pressure variability lelt ventrlcularmass index
  • 相关文献

参考文献13

二级参考文献38

  • 1余灯广,杨祥良,徐辉碧,曾繁典.三维打印技术在药剂学中的应用[J].中国新药杂志,2005,14(7):843-848. 被引量:14
  • 2苏定冯.血压波动性在高血压药物治疗中的意义[J].世界临床药物,2005,26(10):586-588. 被引量:14
  • 3张维忠.血压变异和晨峰的概念及其临床意义[J].中华心血管病杂志,2006,34(3):287-288. 被引量:300
  • 4王文,邓卿,王宪衍,马丽媛,路方红,崔家玉,张放,周宏研,张鹏强,张亮清,王守富,张路毅,林金秀,郑志荣,黄萍,金翠燕,施东伟,王剑英,李丽,郄曙光,舒聃,龚辉,吕家珍,张华茹,饶萍,袁光雷,王卫国,曹东平,方渭清,龚兰生,刘力生,降压治疗预防脑卒中研究协作组.6年降压治疗对脑血管病患者脑卒中再发事件的预防效果[J].中华高血压杂志,2007,15(4):281-284. 被引量:13
  • 5卫生部心血管病防治研究中心.中国心血管病报告2006[M].北京:中国大百科全书出版社,2007.
  • 6Liu L,Zhang Y,Liu G,et al.The Felodipine Event Reduction (FEVER) Study:a randomized long-term placebo-controlled trial in Chinese hypertensive patients[J].J Hypertens,2005,23(12):2157-2572.
  • 7Sever PS,Dahlf B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomised controlled trial[J].Drugs,2004,64(2):43-60.
  • 8Weber MA,Bakris GL,Dahlof B,et al.Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial:a hypertensive population at high cardiovascular risk[J].Blood Press,2007,16(1):13-19.
  • 9ParatiG,Mancia G.Ambulatory blood pressuremonitoning in clinical practice[J].J Hypertens,2002(20):1925-1927.
  • 10Bianchi S,Bigazzi R,Baldari G,et al.Diurnalvariations of blood pressure and microalbu-minruia in essential bypestension[J].Am J Hypentens,1994(7):23.

共引文献442

同被引文献82

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部